illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. 89bio
Company logo

89bio | Sustainability Performance

https://www.89bio.com
Linkedin

Develops pegozafermin for liver and cardiometabolic diseases; wholly owned by Roche since October 2025.

2018

United States

51 - 200 employees

Biotechnology

$0 - 100K in revenue

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#7364
Overall
#1560
in United States
#148
in Biotechnology

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview

View similiar companies

Company logo
Arcturus Therapeutics

United States, Hospital & Health Care, Biotechnology

Company logo
NeueHealth

United States, Hospital & Health Care, Hospital & Health Care

Company logo
Envista

United States, Hospital & Health Care, Medical Device

Reporting

Not reporting on Sustainability

Not committed to key sustainability initiatives

Sustainability employees

    Available in
    Scale package

    Access
  • Email
  • Email